000			02013 a2200577 4500
005			20250515194415.0
264		0	_c20100506
008			201005s 0 0 eng d
022			_a1464-3405
024	7		_a10.1016/j.bmcl.2009.10.102 _2doi
040			_aNLM _beng _cNLM
100	1		_aArgiriadi, Maria A
245	0	0	_a2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode. _h[electronic resource]
260			_bBioorganic & medicinal chemistry letters _cJan 2010
300			_a330-3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenosine Triphosphate _xchemistry
650	0	4	_aAnti-Inflammatory Agents _xchemical synthesis
650	0	4	_aBinding Sites
650	0	4	_aBinding, Competitive
650	0	4	_aComputer Simulation
650	0	4	_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors
650	0	4	_aProtein Kinase Inhibitors _xchemical synthesis
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aPyrimidines _xchemical synthesis
650	0	4	_aStructure-Activity Relationship
700	1		_aEricsson, Anna M
700	1		_aHarris, Christopher M
700	1		_aBanach, David L
700	1		_aBorhani, David W
700	1		_aCalderwood, David J
700	1		_aDemers, Megan D
700	1		_aDimauro, Jennifer
700	1		_aDixon, Richard W
700	1		_aHardman, Jennifer
700	1		_aKwak, Silvia
700	1		_aLi, Biqin
700	1		_aMankovich, John A
700	1		_aMarcotte, Douglas
700	1		_aMullen, Kelly D
700	1		_aNi, Baofu
700	1		_aPietras, M
700	1		_aSadhukhan, Ramkrishna
700	1		_aSousa, Silvino
700	1		_aTomlinson, Medha J
700	1		_aWang, Lu
700	1		_aXiang, Tao
700	1		_aTalanian, Robert V
773	0		_tBioorganic & medicinal chemistry letters _gvol. 20 _gno. 1 _gp. 330-3
856	4	0	_uhttps://doi.org/10.1016/j.bmcl.2009.10.102 _zAvailable from publisher's website
999			_c19305557 _d19305557